Citigroup’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,876
| Closed | -$11.6K | – | 5015 |
|
|
2023
Q4 | $11.6K | Buy |
2,876
+2,861
| +19,073% | +$11.6K | ﹤0.01% | 4395 |
|
|
2023
Q3 | $40 | Sell |
15
-6,014
| -100% | -$16K | ﹤0.01% | 4773 |
|
|
2023
Q2 | $56.3K | Buy |
+6,029
| New | +$56.3K | ﹤0.01% | 3902 |
|
|
2023
Q1 | – | Sell |
-115
| Closed | -$573 | – | 5054 |
|
|
2022
Q4 | $573 | Sell |
115
-142
| -55% | -$708 | ﹤0.01% | 4695 |
|
|
2022
Q3 | $1K | Sell |
257
-916
| -78% | -$3.56K | ﹤0.01% | 4887 |
|
|
2022
Q2 | $6K | Buy |
1,173
+724
| +161% | +$3.7K | ﹤0.01% | 4816 |
|
|
2022
Q1 | $5K | Sell |
449
-2,698
| -86% | -$30K | ﹤0.01% | 5037 |
|
|
2021
Q4 | $40K | Buy |
+3,147
| New | +$40K | ﹤0.01% | 4414 |
|